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Smoking is associated with poorer health outcomes for both African and European 
Americans. In order to better understand whether ethnic-specific genetic variation may 
underlie some of these differences, we compared the smoking-associated genome-
wide methylation signatures of African Americans with those of European Americans, 
and followed up this analysis with a focused examination of the most ethnically divergent 
locus, cg19859270, at the GPR15 gene. We examined the association of methylation at 
this locus to the rs2230344 SNP and GPR15 gene and protein expression. Consistent 
with prior analyses, AHRR residue cg05575921 was the most differentially methylated 
residue in both African Americans and European Americans. However, the second most 
differentially methylated locus in African Americans, cg19859270, was only modestly 
differentially methylated in European Americans. Interrogation of the methylation status 
of this CpG residue found in GPR15, a chemokine receptor involved in HIV pathogen-
esis, showed a significant interaction of ethnicity with smoking as well as a marginal 
effect of genotype at rs2230344, a neighboring non-synonymous SNP, but only among 
African Americans. Gene and protein expression analyses showed that demethylation 
at cg19859270 was associated with an increase in both mRNA and protein levels. 
Since GPR15 is involved in the early stages of viral replication for some HIV-1 and HIV-2 
isolates, and the prevalence of HIV is increased in African Americans and smokers, 
these data support a possible role for GPR15 in the ethnically dependent differential 
prevalence of HIV.
Keywords: epigenetics, smoking, gPr15, ahrr, african americans, european americans, hiV, ethnicity
introduction
Smoking is the largest preventable cause of morbidity and mortality in the United States (1). Each 
year, nearly half a million Americans die from the complications of smoking. Smoking exerts its 
effects by increasing mortality through more “traditional” disorders such as chronic obstructive 
pulmonary disease (COPD), heart disease, and stroke.
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In efforts to understand sources of increased risk for mortality 
through these diseases and other smoking-associated disorders, 
a large number of genome-wide association studies (GWAS) of 
genetic variation have been conducted (2–5). Despite the strong 
heritable contribution to many of these complex disorders, 
GWAS have identified only a small fraction of the total genetic 
component. This lack of success in identifying the “hidden 
genetic variation” underlying these illnesses limits our ability 
to translate sequence-based findings into tools with significant 
impact on treatment or diagnosis. Although there may be many 
reasons for these failures, one commonly cited problem is the 
confounding of potential genetic signals by gene–environment 
interactions (GxE) (6, 7). One of the important confounders may 
be smoking (8).
The failure to understand the genetic architecture of these 
smoking-related illnesses is a substantial problem. Unfortunately, 
like many illnesses, the burden of smoking-related illness is not 
shared equitably. For example, with respect to ethnicity, even after 
adjustment for the usual covariates such as access to health care, 
African Americans are more likely than European Americans to 
suffer adverse outcomes for many smoking-related illnesses such 
as lung cancer and heart disease (9, 10). Subtle or non-additive 
genetic differences may underlie these differential vulnerabilities. 
The challenge lies in establishing a research paradigm through 
which sources of hidden genetic variance can be more readily 
identified and the search narrowed.
Ironically, an improved understanding of genetic contribu-
tions to smoking-related illnesses may come about through a 
better understanding of the epigenetic influences of smoking 
on the genome. In early 2012, we demonstrated that smoking 
is associated with genome-wide changes in DNA methylation, 
with the most sensitive changes being noted at the aryl hydro-
carbon receptor repressor (AHRR) (11). These findings have 
been extensively replicated with demethylation at AHRR CpG 
residue cg05575921 being consistently the top or second most 
prominent change in eight consecutive independent genome-
wide analyses of European and African Americans of all ages 
(12–19). However, not all residues show such consistent change 
in response to smoking. In particular, cg19859270, a residue 
in G-protein-coupled receptor 15 (GPR15), is not significantly 
differentially methylated early in new-onset smokers, and in 
our cursory review of genome-wide methylation studies of 
adult smokers, seemed to be more differentially methylated in 
studies of African Americans compared with those of European 
Americans.
GPR15 is a particularly intriguing candidate for contributing 
to “hidden” variance for smoking-associated illness. This small 
chromosome 3 gene (1254  bp mRNA) codes for a chemokine 
receptor (a.k.a. Brother of Bonzo or BOB) that acts as a co-
receptor for human immunodeficiency virus (HIV) type 2 and 
is capable of serving as a co-receptor for some HIV-1 isolates 
(20–22). These observations are relevant to the identification of 
hidden variance for complex illness for two reasons. First, even 
after controlling for exposure and health care accessibility vari-
ables, African Americans are more likely to be infected with HIV 
and die from smoking-related cancer and coronary artery disease 
(CAD) than European Americans (23). Second, smoking is a 
major risk factor for these illnesses. When taken together, these 
observations suggest that GPR15 may be an ideal locus through 
which to develop an understanding of how hidden genetic vari-
ance may interact with environmental factors, such as tobacco 
smoke, in fulminating illness.
Therefore, in this study, we extend our prior study of adult 
female African Americans by conducting additional genome-
wide methylation analyses of male European and African 
Americans. We then describe an integrated set of follow-up 
experiments at the locus with the most discrepant methylation 
changes to investigate whether ethnic contextual effect of smok-
ing on cg19859270 (GPR15) methylation is driven by local or 
non-local SNP variation.
Materials and Methods
informed consent
Participants recruited for this study provided written consent to 
participate in this study. All protocols and procedures pertaining 
to Family and Community Health Study (FACHS) were approved 
by the Institutional Review Board at the University of Iowa, the 
University of Georgia, and Iowa State University. All protocols 
and procedures pertaining to the Behavioral Diagnostics (BD) 
study were approved by the Institutional Review Board at the 
University of Iowa.
genome-Wide Dna Methylation
The genome-wide analysis included 100 adult males from the 
FACHS and a study of substance use performed in collaboration 
with a commercial company, BD (24). Clinical data for the analy-
sis were obtained from structured interviews with an adapted 
form of the Semi-Structured Assessment for the Genetics of 
Alcoholism-II (SSAGA-II) (25). Active smokers were classified 
as smokers while individuals denying use of any tobacco products 
were classified as non-smokers. Subjects were also phlebotomized 
to obtain biomaterial. Characteristics of these subjects are pre-
sented in Table 1. Briefly, of these 100 middle-aged individuals, 
48 were European Americans and 52 were African Americans. 
Nineteen European Americans and 24 African Americans were 
smokers.
TaBle 1 | clinical and demographic characteristics of male subjects 
participating in the genome-wide methylation studies by ethnicity.
european americans african americans
smoker control smoker control
Age 45 ± 8 47.1 ± 8 49.6 ± 6 49.5 ± 7
Smoking status 19 29 24 28
Current average 
cigarettes/day
21 ± 11 11 ± 6
Smoker pack-yearsa
≥1/2 and <10 1 12
≥10 and <20 3 6
≥20 12 6
aTotal number of smoking individuals does not match the number of individuals 
accounted for under pack-years due to missing data points.
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Peripheral mononuclear cell pellets were obtained through 
standard Ficoll purification, and DNA was subsequently extracted 
using standard manufacturer protocol provided in the Qiagen 
(Valencia, CA, USA) DNA Mini Kit. The Illumina (San Diego, 
CA, USA) HumanMethylation450 Beadchip was used to profile 
the genome-wide DNA methylation status across 485,577 CpG 
loci of subjects in this study. This was conducted by the University 
of Minnesota Genome Center (Minneapolis, MN, USA). Details 
of the procedure have been described previously (18).
The beta value at a CpG locus is defined as the ratio between the 
methylated probe intensity and the total intensities of methylated 
and unmethylated probes. The average beta value at each locus 
was determined using the Illumina Genome Studio Methylation 
Module Version 3.2, and values with a detection p-value greater 
than 0.05 were removed using a PERL script.
The genome-wide data were analyzed using the MethLAB 
Version 1.5 (26), an R package, as previously described (13). 
Smoking-related differential methylation between smokers and 
non-smokers was assessed while controlling for ethnicity, slide, 
and plate effects. Correction for multiple comparisons was con-
ducted using the method of Benjamini–Hochberg in MethLAB at 
the 0.05 significance level (27). Likewise, a similar genome-wide 
analysis was performed separately to determine the differential 
methylation of each ethnicity. For this analysis, the genome-wide 
DNA methylation was analyzed with respect to smoking status 
while controlling for slide and plate effects.
genotyping rs2230344
In order to test if the effect of smoking on cg19859270 (GPR15) 
methylation is ethnically or genetically contextual, we genotyped 
the only common non-synonymous sequence polymorphism 
(rs2230344) in the immediate proximity of cg19859270. Since 
there is no effect of gender on methylation at the cg19859270 
locus (data not shown), in order to increase the power of our 
analyses, we also profiled this genotype in the female subjects from 
the FACHS (n = 111) and BD (n = 14) cohorts. This increased 
our sample size from 100 to 225. Whole blood DNA from these 
individuals was genotyped for the rs2230344 SNP using the SNP 
Genotyping Assay (Life Technologies, Carlsbad, CA, USA) and 
standard manufacturer protocol. Samples alongside the geno-
typing solution were plated in a 384-well plate. Genotyping at 
rs2230344 was conducted as previously described using reagents 
from Applied Biosystems (Foster City, USA) (24). Of the 225 
individuals, 219 were successfully genotyped. The genotype was 
coded as either 0 for the absence of the minor T allele (i.e., C,C 
genotype) or 1 for the presence of at least one minor T allele (i.e., 
C,T and T,T genotypes).
real-Time Pcr for gene expression 
Quantification
Of the 219 successfully genotyped individuals, 121 African 
American subjects had lymphoblast cell lines that were available 
for gene expression profiling. RNA from these subjects extracted 
from lymphoblast cell lines using the standard manufacturer 
protocol of PureLink RNA Mini Kit (Life Technologies) was used 
for GPR15 gene expression profiling. RNA from these samples 
was reverse transcribed to cDNA using standard manufacturer 
protocol of the High-Capacity cDNA Reverse Transcription Kit 
(Life Technologies). After conversion, samples were loaded in 
duplicates in a 384-well plate alongside two housekeeping genes, 
LDHA and RPL7A. The TaqMan gene expression assays were used 
(Life Technologies). Gene expression profiling was conducted in 
an ABI 7900HT Fast Real-Time PCR system (Life Technologies), 
and the resulting Ct values were exported. GPR15 Ct values were 
normalized using the Ct geometric mean values of LDHA and 
RPL7A housekeeping genes.
Western Blot for Protein Quantification
Peripheral blood mononuclear cell pellets from 10 individuals 
were used: five with highest and five with lowest methylation 
at cg19859270. Cells were treated in lysis buffer (Cell Signaling 
Technology, Beverly, MA, USA) for 15 min and sonicated briefly. 
Lysates were separated by polyacrylamide gel electrophoresis 
and transferred to a nitrocellulose membrane. Membranes 
were incubated in protein-free blocking buffer (Thermo Fisher 
Scientific, Waltham, MA, USA) for 1  h at room temperature, 
followed by incubation with primary antibody (1:1000 dilution). 
Immunoreactive proteins were detected with Amersham ECL 
(GE Healthcare, Pittsburgh, PA, USA) using a Kodak Imager. 
Images were analyzed by ImageJ software (NIH).
regression analyses
All regression analyses of methylation at cg19859270, rs2230344 
genotype, and GPR15 gene expression were conducted in JMP 
Version 9 (SAS Institute, Cary, NC, USA).
results
genome-Wide Dna Methylation analyses
Table  1 describes the key demographic characteristics of the 
100 male subjects from the FACHS and BD cohorts whose data 
are included in the genome-wide contrasts of smoking status. 
In total, peripheral mononuclear cell (a.k.a. PBMC or lympho-
cyte pellet) DNA from 52 African Americans (24 smokers, 28 
non-smokers) and 48 European Americans (19 smokers and 
29 non-smokers) were included in the genome-wide analysis. The 
European American subjects were slightly younger and smoked 
more cigarettes on average in a day.
As a first step, the genome-wide methylation data from all 
male subjects (n = 100) were analyzed together with respect to 
smoking status, controlling for ethnicity, slide, and plate effects. In 
this initial analysis, a total of 404 CpG loci were significantly dif-
ferentially methylated at the 0.05 level after Benjamini–Hochberg 
correction for multiple comparisons. The 30 most significant loci 
are shown in Table 2.
Consistent with our prior genome-wide analysis conducted on 
FACHS females (18), probes cg05575921 (ranked first in males 
and second in females) and cg23576855 (ranked seventh in 
males and fifth in females) from the AHRR gene and cg19859270 
(ranked sixth in males and first in females) from the GPR15 gene 
were highly ranked. However, the cg03636183 probe (ranked fifth 
in males) from the coagulation factor II (thrombin) receptor-like 
3 (F2RL3) gene is apparent in male but not female smokers (18). 
On average, at these four highly ranked loci in the males, smokers 
TaBle 2 | The 30 most significantly associated probes with respect to smoking status after genome-wide correction.
Probe iD gene Placement island status average beta values T-test corrected p-value
smokers non-smokers
cg05575921 AHRR Body N_Shore 0.67 0.85 5.31E−18 2.58E−12
cg01940273 Island 0.49 0.59 7.85E−14 1.91E−08
cg05951221 Island 0.29 0.38 4.69E−13 7.59E−08
cg21566642 Island 0.36 0.47 8.77E−13 1.07E−07
cg03636183 F2RL3 Body N_Shore 0.54 0.66 1.70E−11 1.65E−06
cg19859270 GPR15 1st Exon 0.79 0.85 7.61E−10 6.16E−05
cg23576855 AHRR Body N_Shore 0.50 0.67 1.71E−09 1.13E−04
cg26703534 AHRR Body S_Shelf 0.62 0.68 1.86E−09 1.13E−04
cg03329539 N_Shore 0.32 0.37 3.11E−09 1.68E−04
cg06126421 0.64 0.74 4.01E−09 1.95E−04
cg09741592 HNRNPA1 Body S_Shore 0.21 0.24 2.43E−08 1.07E−03
cg10190813 HUS1 Body N_Shore 0.13 0.16 3.90E−08 1.58E−03
cg21161138 AHRR Body 0.62 0.68 9.90E−08 3.70E−03
cg02657160 CPOX Body N_Shore 0.77 0.81 2.17E−07 7.53E−03
cg08709672 AVPR1B 5′UTR S_Shore 0.63 0.66 2.40E−07 7.78E−03
cg25114611 FKBP5 TSS1500 S_Shore 0.28 0.32 2.74E−07 8.31E−03
cg11554391 AHRR Body Island 0.16 0.20 3.15E−07 8.68E−03
cg14656043 CREM 5′UTR S_Shelf 0.18 0.22 3.22E−07 8.68E−03
cg02767841 ZMYND8 TSS1500 0.09 0.11 4.06E−07 1.01E−02
cg15794034 AMICA1 1st Exon 0.07 0.10 4.14E−07 1.01E−02
cg04267000 EHMT2 Body 0.98 0.97 4.97E−07 1.15E−02
cg16451872 UBE3A TSS1500 S_Shore 0.18 0.22 5.50E−07 1.17E−02
cg03450842 ZMIZ1 5′UTR 0.55 0.60 5.54E−07 1.17E−02
cg17580614 ADORA2B Body Island 0.69 0.74 7.61E−07 1.53E−02
cg05649724 Island 0.22 0.26 7.87E−07 1.53E−02
cg09336260 GPR34 1st Exon 0.19 0.24 9.35E−07 1.70E−02
cg08170227 ACTN1 Body 0.48 0.52 9.67E−07 1.70E−02
cg05003417 NARF 5′UTR Island 0.05 0.06 9.84E−07 1.70E−02
cg01692968 N_Shore 0.34 0.40 1.02E−06 1.70E−02
cg13245152 PAX6 Body S_Shore 0.25 0.28 1.10E−06 1.78E−02
All average methylation values are non-log-transformed beta values. Island status refers to the position of the probe relative to the island. Classes include (1) Island, (2) N (north) 
shore, (3) S (south) shore, (4) N (north) shelf, (5) S (south) shelf, and (6) blank denoting that the probe does not map to an island.
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tended to be consistently hypomethylated which conventionally 
is attributed to increased gene expression.
Because of our informal observations and the work of Elliott 
and colleagues who have also noted discrepancies between ethnic 
groups (19), we next analyzed genome-wide DNA methylation 
with respect to smoking status for each ethnic group. The results 
for the smaller European American cohort were less robust. After 
correction for genome-wide contrasts, only one locus, AHRR 
residue cg05575921, was significantly differentially methylated. 
A list of the 30 most significant loci and the average methylation 
for the cases and controls are shown in Table 3.
In contrast, for the larger African American cohort, after 
genome-wide correction, 84 CpG loci remained significantly 
differentially methylated at the 0.05 level. A list of the 30 most 
significant loci and the average methylation in the case and 
control samples are shown in Table 4.
Comparison and contrast of the relative ranking of the findings 
of the two groups were illuminating. Consistent with our obser-
vations formed by the review of the previous literature, GPR15 
residue cg19859270 (ranked second in African American males) 
was the 26,702nd ranked probe in the European American cohort 
(see Table 4). Also, the cg03636183 locus from the F2RL3 gene 
was highly ranked in African Americans (ranked sixth) and not 
in the European Americans (ranked 154th). In fact, outside the 
AHRR (cg05575921) and the three intergenic loci (cg05951221, 
cg01940273, and cg21566642), which map to a CpG island rich 
in transcription factor motifs approximately 9  kb upstream of 
the ALPPL2 locus, there seems to be little correspondence in the 
relative rankings of the probes between the two cohorts, suggest-
ing the possibility that ethnic-specific genetic variation may be 
influencing the degree of smoking-associated DNA methylation 
at a majority of loci.
Focus on gPr15
Since our initial analyses seemed to confirm our prior impres-
sions that GPR15 was more prominently differentially methyl-
ated in African American smokers, we focused our inquiry on 
GPR15. Figure 1 illustrates key features of this chromosome 3 
TaBle 3 | The 30 most significantly differentially methylated probes with respect to smoking status after genome-wide correction in european 
americans (ea) and the corresponding probe ranking in african americans (aa).
Probe iD gene Placement island status rank in aa aa ea
average beta values average beta values
smokers non-smokers smokers non-smokers
cg05575921 AHRR Body N_Shore 1 0.65 0.80 0.70 0.90
cg01940273 Island 8 0.48 0.58 0.50 0.60
cg04359418 Island 382,980 0.82 0.82 0.81 0.87
cg21475150 RPL31 TSS1500 Island 388,413 0.84 0.85 0.78 0.84
cg15633035 IL6R 3′UTR 117,278 0.33 0.37 0.34 0.42
cg21566642 Island 9 0.37 0.48 0.35 0.46
cg05951221 Island 7 0.28 0.37 0.31 0.40
cg17179314 CHRNB4 TSS1500 Island 351,840 0.60 0.61 0.55 0.60
cg03827423 ISCU TSS1500 N_Shore 441,480 0.03 0.03 0.03 0.05
cg17581065 CCDC42 Body 426,434 0.94 0.94 0.91 0.92
cg22888484 SNHG11 TSS200 N_Shore 271,892 0.07 0.06 0.04 0.06
cg19731612 NSD1 TSS1500 Island 206,301 0.71 0.73 0.63 0.76
cg17367884 TBC1D16 Body Island 307,634 0.80 0.79 0.85 0.87
cg03114244 FEN1 5′UTR Island 53,788 0.02 0.03 0.01 0.02
cg23193759 C10orf35 TSS200 Island 86,696 0.16 0.18 0.13 0.16
cg16568472 ITPA Body S_Shore 231,862 0.15 0.05 0.05 0.05
cg26703534 AHRR Body S_Shelf 333 0.62 0.67 0.63 0.69
cg04075184 CLASP1 Body S_Shelf 58,660 0.69 0.72 0.70 0.75
cg02004401 GNA12 3′UTR 249,450 0.65 0.70 0.71 0.78
cg00476430 PAG1 5′UTR 75,788 0.77 0.80 0.82 0.79
cg01760846 PSMC1 TSS200 N_Shore 342,153 0.17 0.17 0.17 0.21
cg10068330 244,013 0.60 0.61 0.69 0.64
cg21053365 ZNF425 Body N_Shore 363,555 0.05 0.05 0.05 0.06
cg16168311 APOA1BP Body S_Shore 36,107 0.21 0.23 0.12 0.14
cg14519950 C9orf68 Body Island 29,587 0.05 0.06 0.05 0.06
cg10200202 RGS10 Body 44,756 0.08 0.09 0.07 0.09
cg10755899 Island 70,761 0.81 0.82 0.81 0.87
cg12864389 PLEC1 Body Island 41,579 0.20 0.22 0.20 0.26
cg13910681 FAM102A Body N_Shore 17,620 0.15 0.17 0.14 0.18
cg04799493 5,613 0.92 0.90 0.91 0.90
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locus. GPR15 is a single exon gene coding for 1254-bp mRNA 
and a 360 amino acid protein. Overall, the gene region is 
sparsely populated with CpG residues (19 CpG residues in 
the 2300-bp region covering the gene region). There are four 
probes in the Illumina 450K array covering GPR15, cg26385013 
(TSS1500), cg08375941 (TSS1500), cg19859270 (first Exon), 
and cg19614811 (TSS200). In contrast to the strong signal at 
cg19859270, methylation at the other three GPR15 CpG residues 
is not significantly associated with smoking status [cg26385013 
(p-value <0.90), cg08375941 (p-value <0.39), and cg19614811 
(p-value <0.10)].
The rs2230344 polymorphism was chosen because it is the only 
common sequence polymorphism in the immediate proximity of 
cg19859270 (310 bp upstream). Review of the dbSNP database 
shows this to be a C to T polymorphism resulting in a Proline or 
Serine, respectively, at amino acid 37 of GPR15. According to the 
dbSNP database, the minor allele frequency (MAF) is approxi-
mately 0.16 in European Americans and 0.05 in Yorubans (28). 
Using standard methods, we then determined genotype at this 
locus for all subjects. In our European American male subjects, 
the MAF was 0.23 while in our African American male subjects 
the MAF was 0.06.
effect of age, gender, and smoking 
consumption history on cg19859270 
Methylation
As part of the initial inquiry into other variables that may be influ-
encing the degree of methylation at GPR15 residue cg19859270, 
we first examined whether the age/total smoking consumption 
and gender of the smoker might significantly influence meth-
ylation at cg19859720. Fortunately, in prior work, our group 
has conducted genome-wide analyses of smoking in 19-year-old 
African Americans (both genders, n = 399), 22-year-old African 
Americans (males only n  =  107), and adult female African 
Americans (n = 111) using the Illumina 450 K platform (13, 16, 
18). We used these data in combination with the current data set 
of 100 males to understand the effects of age, gender, and smok-
ing exposure. In our contrast of 19- and 22-year-old smokers 
who averaged 1/2 and 1 pack year of consumption, respectively, 
the difference in methylation between the cases and controls at 
TaBle 4 | The 30 most significantly differentially methylated probes with respect to smoking status after genome-wide correction in african americans 
(aa) and the corresponding probe ranking in european americans (ea).
Probe iD gene Placement island status rank in ea aa ea
average beta values average beta values
smokers non-smokers smokers non-smokers
cg05575921 AHRR Body N_Shore 1 0.65 0.80 0.70 0.90
cg19859270 GPR15 1st Exon 26,702 0.78 0.86 0.80 0.84
cg23576855 AHRR Body N_Shore 4,194 0.50 0.68 0.52 0.65
cg09741592 HNRNPA1 Body S_Shore 75,481 0.19 0.23 0.25 0.26
cg02657160 CPOX Body N_Shore 57,537 0.77 0.81 0.77 0.79
cg03636183 F2RL3 Body N_Shore 154 0.52 0.65 0.58 0.68
cg05951221 Island 7 0.28 0.37 0.31 0.40
cg01940273 Island 2 0.48 0.58 0.50 0.60
cg21566642 Island 6 0.37 0.48 0.35 0.46
cg23254918 CD59 TSS200 Island 113,560 0.05 0.06 0.05 0.05
cg06620353 SEC63 Body 284,374 0.93 0.90 0.78 0.77
cg01866630 ITPR3 Body Island 328,999 0.09 0.10 0.08 0.07
cg04120842 PARP4 Body 295,071 0.96 0.95 0.89 0.89
cg25937832 NKIRAS1 5′UTR Island 165,126 0.05 0.06 0.06 0.06
cg10486879 NCRNA00167 Body Island 381,424 0.03 0.03 0.03 0.03
cg26040729 RSF1 Body S_Shore 205,668 0.91 0.89 0.74 0.75
cg26701198 COG6 TSS200 N_Shore 75,566 0.07 0.08 0.07 0.08
cg23028848 TNKS1BP1 TSS200 Island 107,426 0.03 0.04 0.04 0.04
cg01345087 SYN1 5′UTR Island 153,964 0.04 0.05 0.04 0.08
cg07904448 ZNF529 5′UTR Island 201,311 0.06 0.07 0.06 0.06
cg11835582 FBXO8 1st Exon Island 364,823 0.04 0.05 0.04 0.04
cg03904534 WWOX Body 306,400 0.98 0.97 0.94 0.94
cg04267000 EHMT2 Body 55,247 0.98 0.97 0.98 0.98
cg02632643 CD320 Body N_Shelf 228,457 0.96 0.95 0.96 0.95
cg14405773 CSH2 Body 272,998 0.98 0.98 0.97 0.97
cg26858409 ZFP64 Body S_Shore 90,596 0.89 0.90 0.88 0.89
cg19111030 ANKRD53 TSS1500 N_Shore 350,384 0.18 0.20 0.18 0.19
cg23093692 SLC35F3 Body Island 94,323 0.79 0.73 0.74 0.70
cg11556164 LRRN3 5′UTR 231,425 0.70 0.77 0.70 0.72
cg22949575 ASPSCR1 Body N_Shelf 286,780 0.97 0.96 0.94 0.94
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FigUre 1 | Position of illumina gPr15 methylation probes. The position of Illumina GPR15 methylation probes per the UCSC Genome Browser (http://
genome.ucsc.edu). The genome-wide corrected p-values for the CpG residue probes are p-value <0.90, p-value <0.39, p-value <0.10, and p-value <6.2E−05, 
respectively (left to right).
FigUre 2 | relative ratio of gPr15/actin. The figure depicts the relative 
ratio of GPR15/Actin for each PBMC cell pellet. H1 through H4 represent the 
four samples with the highest cg19859270 methylation, whereas L1 through 
L4 represent four samples with the lowest cg19859270 methylation.
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cg19859270 is 0.01 (nominal p-value <0.002, rank 863) and 0.02 
(nominal p-value <0.0006, rank 164), respectively. Finally, using 
the combined data from the current male and previously exam-
ined female African Americans, we examined the effect of gender 
on methylation and found no significant effect (p < 0.9). Taken 
as a whole, the data indicate that the changes in cg19859270 
methylation are incremental and dose dependent, but not grossly 
influenced by gender.
effect of smoking, ethnicity, and genotype on 
cg19859270 Methylation
As the next step, we tested whether the effect of smoking on 
cg19859270 methylation is ethnically or genetically contextual. 
To do this, we constructed a model stipulating methylation at 
cg19859270 as the dependent variable, with ethnicity, rs2230344 
genotype, smoking status, and their interactive terms (e.g., eth-
nicity × smoking status) as independent variables.
Overall, the model was highly significant with an adjusted R2 
of 0.54 (p-value <0.0001). Smoking status had a highly significant 
main effect [sum of squares (SS) = 0.16, p-value <0.0001], a trend 
for a main effect of genotype (SS = 0.005, p-value <0.06) with no 
significant main effects of ethnicity (SS = 0.0004, p-value <0.59). 
The interaction term between ethnicity and smoking status was 
significant (SS = 0.013, p-value <0.002), but there were no effects 
for the other three interaction terms. In short, the model supports 
the hypothesis that factors segregating with ethnicity moderate 
the effects of smoking on DNA methylation at cg19859270.
Because of the interaction effect of ethnicity with smoking 
status, we then tested the relationship of rs2230344 genotype to 
cg19859270 methylation for each ethnicity using both smoking 
status and genotype as independent variables and incorporating 
an interaction term of genotype with smoking status. The overall 
models were highly significant for both groups with the proportion 
of the variance accounted for by the model for African Americans 
(adjusted R2 = 0.61, p-value <0.0001) being considerably larger 
than that for European Americans (adjusted R2 = 0.20, p-value 
<0.002). In both models, smoking was the largest predictor of 
cg19859270 methylation (p-value <0.0001). However, in contrast 
to the European Americans, there was a significant main effect of 
rs2230344 genotype in the African American subjects (p < 0.05), 
suggesting that methylation level in African Americans is affected 
not only by smoking status but also by the SNP. On the contrary, 
methylation in European Americans is only affected by smoking 
status.
effect of smoking status and rs2230344 snP 
genotype on gPr15 rna and Protein levels
In previous work, we have shown that smoking-associated 
changes in peripheral blood DNA are reflected, but attenuated 
in lymphoblast cell lines prepared from those blood cells (11). 
Because alterations in DNA methylation are associated with 
changes in gene expression and there is evidence for the effect of 
rs2230344 genotype on methylation only in African Americans, 
we next examined whether rs2230344 genotype was associ-
ated with changes in GPR15 gene expression using RNA from 
lymphoblast cell lines prepared from 121 African American 
participants characterized for smoking status (81 non-smokers 
and 40 smokers) and enriched for the rs2230344 T allele (95 
CC, 23 CT, and 3 TT) using a general linear modeling approach. 
Genotypes were grouped into two groups: absence of minor T 
allele and presence of at least one minor T allele. Overall, the 
model that included genotype, smoking status, and their interac-
tion term accounted for 9% of the variance (adjusted R2 = 0.086, 
p-value <0.004) with significant main effects of smoking status 
(SS =  2.98, p-value <0.03) and a trend toward significance for 
both genotype (SS =  1.72, p-value <0.10) and the interaction 
term (SS = 2.15, p-value <0.07).
Finally, we examined whether cg19859270 methylation was 
associated with GPR15 protein expression. We utilized lympho-
cyte pellets from the BD cohort to determine the extent to which 
protein expression was influenced by methylation at cg19859270. 
The relative level of GPR15 protein was measured in 10 individu-
als, five with the highest and five with the lowest methylation lev-
els at cg19859270. Results from two failed samples were excluded 
from the analysis (one high and one low methylation). Protein 
levels normalized to actin housekeeping protein was inversely 
correlated with methylation (p-value <0.01). Figure 2 illustrates 
the results. As can be seen, all four of the less methylated cells 
show greater relative production of GPR15 protein than any of 
the cells with a high level of methylation, indicating a substantial 
association between protein production and gene methylation 
at cg19859270. Figure S1 in Supplementary Material depicts the 
protein expression in immunoblot gels.
Discussion
In summary, our results demonstrate that methylation of a 
region in the GPR15 cytokine receptor in response to a common 
environmental factor, tobacco smoke, is dependent on factors, 
presumably genetic, which sort with ethnicity. Given the nature 
of the receptor, it is plausible that it may have implications for 
understanding ethnicity-related disparities in health outcomes 
associated with smoking. In addition, these results suggest that 
this ethnic-sensitive response is not unique and that many addi-
tional ethnically sensitive responses to tobacco smoke may exist, 
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suggesting ethnicity-specific pathway to a number of important 
smoking-related health outcomes.
As compared to better-known chemokine receptors involved 
with HIV transmission such as CCR5, the cellular roles of GPR15 
are less well understood. As a co-receptor for HIV-2, SIV, and 
some HIV-1 isolates, this chemokine receptor has an established 
role in facilitating efficient intracellular transport of certain 
strains of HIV-1, HIV-2, and SIV (20, 21, 29, 30). In addition, 
increased expression of the receptor is essential for homing of 
regulatory T-lymphocytes to the gut, and GPR15 signaling plays 
a key role in moderating gastrointestinal immune tolerance (31). 
This prior understanding suggests two potential roles for GPR15 
in moderating ethnic-specific differences in susceptibility to both 
retrovirus infection and subsequent disease course.
Smoking-induced increases in GPR15 expression may play a 
role in HIV pathogenesis by increasing the susceptibility of CD4+ 
T cells for some HIV-1 isolates (21, 32). However, secondary to a 
number of factors, this role may not be consistent in all populations, 
and before considering potential mechanisms, it is important to 
understand the limitations of earlier epidemiological studies. At 
the present time, of the approximately 40,000,000 individuals 
living with HIV (both HIV-1 and HIV-2), nearly two-thirds are 
from sub-Saharan Africa, the region from which the majority of 
African Americans in the United States draw the vast majority of 
their genetic heritage. Unfortunately, because smoking associates 
with many other factors that are independently associated with 
HIV risk, such as IV drug use and risky sex, a direct relationship 
of HIV infection with smoking is difficult to establish. However, 
in 2007, Furber and colleagues conducted a meta-analysis of the 
relationship of smoking to both HIV seropositivity and progres-
sion (33). Of the six studies with adequate control for potential 
confounders that examined the relationship of smoking to HIV 
seroconversion, five demonstrated a significant relationship 
between smoking and HIV seroconversion. Significantly, the only 
study not to demonstrate a significant relationship was a study 
conducted in 1991 of a cohort that was 89% European American 
(34). In contrast, all three studies of individuals of African ancestry 
showed robust independent effects of smoking on seroconversion 
(35–37). Taken as a whole, these data strongly support the pos-
sible existence of ethnic-specific factors in determining elevated 
HIV seroconversion rates in response to smoking. Differential 
GPR15 methylation may play a role in accounting for a portion 
of that differential vulnerability.
GPR15’s role in targeting lymphocytes to the gastrointestinal 
tract suggests the possibility that smoking may exacerbate HIV-
associated enteropathy (30, 38). Optimal gastrointestinal func-
tion is facilitated by the presence of a symbiotic gut biome whose 
composition is regulated, in part, by interactions with regulatory 
lymphocytes in the intestinal mucosa. Dysregulation of the lym-
phocyte–biome interplay results in altered epithelial permeabil-
ity, disruptions of mucosal integrity and at the clinical level both 
malabsorption and diarrhea. Although the exact mechanisms 
through which this is accomplished is not yet known, HIV-1 
infection directly disrupts mucosal integrity and permeability 
(39). Therefore, even in the absence of facilitating retrovirus 
infectivity, by increasing the expression of GPR15 on lymphocytes 
and presumably the proportion of lymphocytes segregating to the 
gut, smoking may be exacerbating gastrointestinal dysfunction. 
Consistent with this hypothesis is the observation that clinicians 
routinely recommend smoking cessation to patients with AIDS 
enteropathy (40). However, even if altered GPR15 has a role in 
HIV enteropathy, a generalizable role for smoking-associated 
altered GPR15 expression in exacerbating HIV progression is 
unlikely because in the review of Furber and colleagues, 9 of the 
10 high-quality studies reviewed found no relationship between 
smoking status and HIV progression (33).
The current studies do not provide the exact identity or loca-
tion of the genetic variation of the smoking-associated changes 
in GPR15 expression. Despite the weak, yet convergent data that 
the rs2230344 SNP is associated with smoking dependent effects 
in biomaterial from African Americans, the fact that this non-
synonymous SNP has no significant effect on methylation in DNA 
from European Americans demonstrates that this coding poly-
morphism is not sufficient by itself to trigger smoking-associated 
changes in gene and protein expression. Instead, these data sug-
gest that other genetic variation co-segregating on the haplotype 
defined by the rs2230344 SNP acting alone, or in combination 
with other trans factors, may be responsible for the smoking-
associated effect. The latter is a particularly intriguing possibil-
ity. Examination of the single exon GPR15 locus surrounding 
rs2230344 in the UCSC genome browser (41) demonstrates it to 
be rich in transcription factor binding sites. However, in order to 
rigorously test this hypothesis, large-scale studies that incorporate 
extensive resequencing will be required. Conversely, it is also pos-
sible that environmental factors co-segregating with smoking, but 
differing by ethnicity, may be responsible for the observed effects. 
Again, testing this hypothesis would require large-scale studies 
that rigorously interrogate environmental factors.
Combined with other recently published results, our data 
suggest that the ethnically contextual effects of smoking are not 
limited to GPR15 or to comparisons of African Americans with 
European Americans. Recently, Elliott and associates reported 
the results of a genome-wide association of DNA from 192 
subjects of European and South Asian descents (19). Although 
they did not specifically examine genetic variation at any locus, 
they found evidence of ethnic-specific differences at several loci 
and suggested that ethnic differences in smoking-evoked DNA 
methylation may provide vital clues to disease pathways that 
differ by ethnicity. Our results provide specific explication of 
that assertion with the breadth of the discrepant findings in our 
analysis suggesting that the vast majority of the highly ranked 
loci may contain ethnic-specific variation affecting local DNA 
methylation changes in response to smoking.
Taken in context with other studies, these results give addi-
tional credence to prior suggestions that genome-wide genetic 
searches for the “hidden variance” associated with common 
complex medical disorders could benefit from incorporation of 
epigenetic information at the genome-wide level (42, 43). For 
example, with respect to cardiovascular disease, Breitling and 
colleagues have shown that methylation status at F2RL3, which 
codes for protease-activated receptor 4 (PAR-4), is strongly 
associated with mortality in those with coronary heart disease 
(44, 45). Since coagulation-related outcomes figure prominently 
in CAD-related mortality, one might expect that variation at 
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this locus might be highly associated with CAD and genome-
wide studies. However, review of several genome-wide analyses 
including one meta-analysis of mixed groups fails to show a 
significant contribution by genetic variation at this locus (3, 5, 
46). Since our current results demonstrate that smoking has a 
strong ethnically contextual effect on F2RL3 methylation, and our 
prior work demonstrates that these smoking-associated effects 
are strongly correlated with other coagulation factor-related loci, 
these results strongly suggest that efforts to identify genetic vari-
ants responsible for CAD should be both stratified for ethnicity 
and smoking exposure.
A critical question is how to identify and control for smoking 
exposure in potentially available, large samples that were not 
collected with reliable biochemical validation of smoking status. 
This is not a trivial question because the majority of currently 
available DNA samples are not well informed with respect to 
smoking status and high-risk populations have the highest rate of 
unreliable self-report data. One particularly attractive possibility, 
given its consistency, may be to use AHRR methylation status as a 
cofactor in analyses to identify smoking exposure. In all popula-
tions surveyed today, we and others have repeatedly shown that 
methylation at AHRR residue cg05575921, which is the binding 
site for a transcriptional enhancer in a key feedback loop in the 
pathway responsible for metabolizing dioxins and polyaromatic 
hydrocarbons, is the most consistently differentially methylated 
residue in smokers. Although there is some evidence that there 
may be some mild ethnic-dependent effects even at this locus, 
our unpublished studies of over 2000 individuals of European 
American, Asian, and African American ancestry indicate 
that average beta value at cg05575921 in lifetime non-smokers 
of all ancestries from the United States is approximately 0.91. 
Unfortunately, use of samples without adequate biochemical vali-
dation can inadvertently result in lower values at this locus. This 
is true even for the current sample taken from the larger, relatively 
high-risk FACHS population (n = 650) in which one fourth of 
those with markedly positive serum cotinine levels denied the use 
of tobacco products (unpublished data). But this is not to say that 
surreptitious smoking might be the only cause of altered basal 
cg05575921 rates observed in the literature. Therefore, although 
the use of cg05575921 as a cofactor in genome-wide analyses may 
improve our power to detect hidden genetic variation, its use is 
not a perfect solution to the problem posed by smoking-induced 
differential methylation. However, it still could be a significant 
improvement.
conclusion
In summary, we report that ethnicity has significant effects on 
genome-wide methylation analyses of the effects of smoking and 
that genotype at rs2230344 is associated with factors that affect 
smoking-induced responses. We suggest that ethnically diverse, 
integrated genetic and methylation approaches may identify 
genetic variation relevant to risk for smoking-related illnesses 
and potentially other non-smoking-related common complex 
disorders.
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